179 related articles for article (PubMed ID: 15900794)
1. Alefacept for the treatment of psoriasis: a review of the current literature and practical suggestions for everyday clinical use.
Korman NJ; Moul DK
Semin Cutan Med Surg; 2005 Mar; 24(1):10-8. PubMed ID: 15900794
[TBL] [Abstract][Full Text] [Related]
2. An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis.
Ortonne JP; Khemis A; Koo JY; Choi J
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):556-63. PubMed ID: 16164708
[TBL] [Abstract][Full Text] [Related]
3. Open-label, single-center, safety dose escalation trial of alefacept for the treatment of moderate to severe chronic plaque psoriasis.
Moul DK; Routhouska SB; Korman NJ
J Cutan Med Surg; 2007; 11(4):132-6. PubMed ID: 17601420
[TBL] [Abstract][Full Text] [Related]
4. Alefacept: its safety profile, off-label uses, and potential as part of combination therapies for psoriasis.
Scheinfeld N
J Dermatolog Treat; 2007; 18(4):197-208. PubMed ID: 17671880
[TBL] [Abstract][Full Text] [Related]
5. Clinical response to alefacept: results of a phase 3 study of intravenous administration of alefacept in patients with chronic plaque psoriasis.
Krueger GG
J Eur Acad Dermatol Venereol; 2003 Jul; 17 Suppl 2():17-24. PubMed ID: 12795771
[TBL] [Abstract][Full Text] [Related]
6. Alefacept: a review of the literature and practical guidelines for management.
Hodak E; David M
Dermatol Ther; 2004; 17(5):383-92. PubMed ID: 15379773
[TBL] [Abstract][Full Text] [Related]
7. Alefacept: an expert review concerning the treatment of psoriasis.
Langley RG; Cherman AM; Gupta AK
Expert Opin Pharmacother; 2005 Oct; 6(13):2327-33. PubMed ID: 16218892
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response.
Lui H; Gulliver W; Tan J; Hong CH; Hull P; Shear NH; Paradiso-Hardy F; Bissonette R
J Drugs Dermatol; 2012 Aug; 11(8):929-37. PubMed ID: 22859237
[TBL] [Abstract][Full Text] [Related]
9. Alefacept for chronic plaque psoriasis: a selective therapy with long-lasting disease remissions and an encouraging safety profile.
Leone G; Rolston K; Spaulding G
Dermatol Nurs; 2003 Jun; 15(3):216-20, 224-5; quiz 226. PubMed ID: 12875010
[TBL] [Abstract][Full Text] [Related]
10. An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis.
Weinberg JM
Clin Ther; 2003 Oct; 25(10):2487-505. PubMed ID: 14667953
[TBL] [Abstract][Full Text] [Related]
11. An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis.
Lebwohl M; Christophers E; Langley R; Ortonne JP; Roberts J; Griffiths CE;
Arch Dermatol; 2003 Jun; 139(6):719-27. PubMed ID: 12810502
[TBL] [Abstract][Full Text] [Related]
12. Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacy.
Lowe NJ; Gonzalez J; Bagel J; Caro I; Ellis CN; Menter A
Int J Dermatol; 2003 Mar; 42(3):224-30. PubMed ID: 12653922
[TBL] [Abstract][Full Text] [Related]
13. The remittive effects of alefacept.
Krueger GG
J Cutan Med Surg; 2004 Dec; 8 Suppl 2():10-3. PubMed ID: 15668750
[TBL] [Abstract][Full Text] [Related]
14. Clinical effectiveness and safety experience with alefacept in the treatment of patients with moderate-to-severe chronic plaque psoriasis in Taiwan: results of an open-label, single-arm, multicentre pilot study.
Huang PH; Liao YH; Wei CC; Tseng YH; Ho JC; Tsai TF
J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):923-30. PubMed ID: 18312328
[TBL] [Abstract][Full Text] [Related]
15. The safety and efficacy of high-dose alefacept compared with a loading dose of alefacept in patients with chronic plaque psoriasis.
Cafardi JA; Cantrell W; Wang W; Elmets CA; Elewski BE
Skinmed; 2008; 7(2):67-72. PubMed ID: 18327010
[TBL] [Abstract][Full Text] [Related]
16. Development and use of alefacept to treat psoriasis.
Krueger GG; Callis KP
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S87-97. PubMed ID: 12894131
[TBL] [Abstract][Full Text] [Related]
17. Alefacept: a novel biologic in the treatment of psoriasis.
Liu CM; McKenna JK; Krueger GG
Drugs Today (Barc); 2004 Dec; 40(12):961-74. PubMed ID: 15645008
[TBL] [Abstract][Full Text] [Related]
18. Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis.
Krueger GG
Expert Opin Biol Ther; 2002 Apr; 2(4):431-41. PubMed ID: 11955280
[TBL] [Abstract][Full Text] [Related]
19. Clinical update on alefacept: consideration for use in patients with psoriasis.
Gade JN
J Manag Care Pharm; 2004 Jun; 10(3 Suppl B):S33-7. PubMed ID: 15253688
[TBL] [Abstract][Full Text] [Related]
20. Alefacept is well tolerated in patients with chronic plaque psoriasis.
Gottlieb AB
J Cutan Med Surg; 2004 Dec; 8 Suppl 2():14-9. PubMed ID: 15668751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
